232 related articles for article (PubMed ID: 10956411)
21. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
22. Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma.
Davis TL; Cress AE; Dalkin BL; Nagle RB
Prostate; 2001 Feb; 46(3):240-8. PubMed ID: 11170153
[TBL] [Abstract][Full Text] [Related]
23. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
Zhou T; Xu C; He M; Sun Y
Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
[TBL] [Abstract][Full Text] [Related]
25. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
26. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
Abdou AG; Aiad HA; Sultan SM
APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
[TBL] [Abstract][Full Text] [Related]
27. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
Front Immunol; 2020; 11():1820. PubMed ID: 33013832
[TBL] [Abstract][Full Text] [Related]
28. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue.
Kitamura H; Torigoe T; Asanuma H; Hisasue SI; Suzuki K; Tsukamoto T; Satoh M; Sato N
Histopathology; 2006 Jan; 48(2):157-61. PubMed ID: 16405664
[TBL] [Abstract][Full Text] [Related]
29. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
Sroka IC; McDaniel K; Nagle RB; Bowden GT
Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
[TBL] [Abstract][Full Text] [Related]
30. Role of androgen receptor in prostatic neoplasia versus hyperplasia.
Husain I; Shukla S; Soni P; Husain N
J Cancer Res Ther; 2016; 12(1):112-6. PubMed ID: 27072221
[TBL] [Abstract][Full Text] [Related]
31. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
32. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of galectin-3 is associated with progression of human breast cancer.
Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
[TBL] [Abstract][Full Text] [Related]
36. Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression.
Yang G; Addai J; Tian WH; Frolov A; Wheeler TM; Thompson TC
Cancer Res; 2004 Mar; 64(6):2076-82. PubMed ID: 15026346
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of galectin-3 in basal cell carcinoma of the skin.
Castronovo V; Liu FT; van den Brule FA
Int J Oncol; 1999 Jul; 15(1):67-70. PubMed ID: 10375595
[TBL] [Abstract][Full Text] [Related]
39. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.
Melling N; Taskin B; Hube-Magg C; Kluth M; Minner S; Koop C; Grob T; Graefen M; Heinzer H; Tsourlakis MC; Izbicki J; Wittmer C; Huland H; Simon R; Wilczak W; Sauter G; Steurer S; Schlomm T; Krech T
Prostate; 2016 Feb; 76(3):259-72. PubMed ID: 26764246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
